Therapy with multipotent mesenchymal stromal cells protects lungs from radiation-induced injury and reduces the risk of lung metastasis

Antioxidants and Redox Signaling

Volumn 24, Issue 2, 2016, Pages 53-69

  Klein, Diana ^a,b   Schmetter, Alexandra ^a,b   Imsak, Roze ^a,b   Wirsdörfer, Florian ^a,b   Unger, Kristian ^b   Jastrow, Holger ^a   Stuschke, Martin ^a   Jendrossek, Verena ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; CD11B ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE; VASCULAR ENDOTHELIAL CADHERIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER RISK; CANCER SIZE; CELL AGING; CELL COMPOSITION; CELL COUNT; CELL DAMAGE; CELL GROWTH; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL REGENERATION; CELL STRUCTURE; CELL SURFACE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; EXTRAVASATION; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IONIZING RADIATION; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM CELL; LUNG INJURY; LUNG METASTASIS; LUNG PROTECTION; MELANOMA; MELANOMA CELL LINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; THERAPY EFFECT; TISSUE LEVEL; TUMOR INVASION; TUMOR SEEDING; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; LUNG; LUNG NEOPLASMS; METABOLISM; RADIATION INJURIES; RADIATION RESPONSE; SECONDARY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; LUNG; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RADIATION INJURIES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84954570998     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6183     Document Type: Article

References (75)

1. Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, and Brown JM. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 107: 8363-8368, 2010.
2. Angelini PD, Zacarias Fluck MF, Pedersen K, Parra-Palau JL, Guiu M, Bernado Morales C, Vicario R, Luque-Garcia A, Navalpotro NP, Giralt J, Canals F, Gomis RR, Tabernero J, Baselga J, Villanueva J, and Arribas J. Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence. Cancer Res 73: 450-458, 2013.
3. Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rodel F, Rodel C, and Fokas E. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 110: 501-509, 2014.
4. Bang OY, Lee JS, Lee PH, and Lee G. Autologous mes-enchymal stem cell transplantation in stroke patients. Ann Neurol 57: 874-882, 2005.
5. Barcellos-Hoff MH, Park C, and Wright EG. Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer 5: 867-875, 2005.
6. Benderitter M, Caviggioli F, Chapel A, Coppes RP, Guha C, Klinger M, Malard O, Stewart F, Tamarat R, Luijk PV, and Limoli CL. Stem cell therapies for the treatment of radiation-induced normal tissue side effects. Antioxid Re-dox Signal 21: 338-355, 2014.
7. Bernier J, Hall EJ, and Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 4: 737-747, 2004.
8. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740, 2007.
9. Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, Schulze-Osthoff K, Fischer U, Kohler D, Stuschke M, and Jendrossek V. New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol 101: 86-92, 2011.
10. Chin SP, Poey AC, Wong CY, Chang SK, Teh W, Mohr TJ, and Cheong SK. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy 12: 31-37, 2010.
11. Chung YL, Jian JJ, Cheng SH, Tsai SY, Chuang VP, Soong T, Lin YM, and Horng CF. Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepato-cellular carcinoma. Clin Cancer Res 12: 2706-2715, 2006.
12. Conese M, Carbone A, Castellani S, and Di Gioia S. Para-crine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases. Cells Tissues Organs 197: 445-473, 2013.
13. Copland IB. Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res 2: 3-13, 2011.
14. Coppe JP, Desprez PY, Krtolica A, and Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5: 99-118, 2010.
15. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, and Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-2868, 2008.
16. Coppes RP, van der Goot A, and Lombaert IM. Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol 19: 112-121, 2009.
17. Craig MJ and Loberg RD. CCL2 (Monocyte Chemoat-tractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev 25: 611-619, 2006.
18. Cummings B, Keane T, Pintilie M, Warde P, Waldron J, Payne D, Liu FF, Bissett R, McLean M, Gullane P, and O'Sullivan B. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Radiother Oncol 85: 7-16, 2007.
19. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, and Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-1806, 2009.
20. Eldh T, Heinzelmann F, Velalakan A, Budach W, Belka C, and Jendrossek V. Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time-and dose-dependent. Strahlenther Onkol 188: 274-281, 2012.
21. Ergun S, Tilki D, and Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 15: 981-995, 2011.
22. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, and Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apo-ptosis. Science 300: 1155-1159, 2003.
23. Ghafoori P, Marks LB, Vujaskovic Z, and Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 22: 37-47; discussion 52-53, 2008.
24. Ghobadi G, Bartelds B, van der Veen SJ, Dickinson MG, Brandenburg S, Berger RM, Langendijk JA, Coppes RP, and van Luijk P. Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension. Thorax 67: 334-341, 2012.
25. Gil-Bernabe AM, Ferjancic S, Tlalka M, Zhao L, Allen PD, Im JH, Watson K, Hill SA, Amirkhosravi A, Francis JL, Pollard JW, Ruf W, and Muschel RJ. Recruitment of monocytes/macrophages by tissue factor-mediated coagu-lation is essential for metastatic cell survival and pre-metastatic niche establishment in mice. Blood 119: 3164-3175, 2012.
26. Gotherstrom C, West A, Liden J, Uzunel M, Lahesmaa R, and Le Blanc K. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 90: 1017-1026, 2005.
27. Graves PR, Siddiqui F, Anscher MS, and Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol 20: 201-207, 2010.
28. Grizzle WE, Mountz JD, Yang PA, Xu X, Sun S, Van Zant GE, Williams RW, Hsu HC, and Zhang HG. BXD recombi-nant inbred mice represent a novel T cell-mediated immune response tumor model. Int J Cancer 101: 270-279, 2002.
29. HamalukicM, Huelsenbeck J, Schad A, WirtzS, Kaina B, and Fritz G. Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors. PLoS One 6: e26413, 2011.
30. Hass R, Kasper C, Bohm S, and Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9: 12, 2011.
31. He Q, Wan C, and Li G. Concise review: multipotent mes-enchymal stromal cells in blood. Stem Cells 25: 69-77, 2007.
32. Hoang T, Huang S, Armstrong E, Eickhoff JC, and Harari PM. Enhancement of radiation response with bevacizumab. J Exp Clin Cancer Res 31: 37, 2012.
33. Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, and Ingenito EP. Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev 20: 1779-1792, 2011.
34. Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, Kim SW, Yang YS, Oh W, and Chang JW. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 14: 17986-18001, 2013.
35. Kaplan RN, Rafii S, and Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 66: 11089-11093, 2006.
36. Kargozaran H, Yuan SY, Breslin JW, Watson KD, Gau-dreault N, Breen A, and Wu MH. A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24: 495-502, 2007.
37. Kern S, Eichler H, Stoeve J, Kluter H, and Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301, 2006.
38. Klein D, Benchellal M, Kleff V, Jakob HG, and Ergun S. Hox genes are involved in vascular wall-resident multi-potent stem cell differentiation into smooth muscle cells. Sci Rep 3: 2178, 2013.
39. Klein D, Demory A, Peyre F, Kroll J, Augustin HG, Helfrich W, Kzhyshkowska J, Schledzewski K, Arnold B, and Goerdt S. Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway. Hepatology 47: 1018-1031, 2008.
40. Klein D, Meissner N, Kleff V, Jastrow H, Yamaguchi M, Ergun S, and Jendrossek V. Nestin(+) tissue-resident mul-tipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling. Front Oncol 4: 169, 2014.
41. Klein D, Weisshardt P, Kleff V, Jastrow H, Jakob HG, and Ergun S. Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS One 6: e20540, 2011.
42. Krtolica A, Parrinello S, Lockett S, Desprez PY, and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98: 12072-12077, 2001.
43. Le ON, RodierF, FontaineF, Coppe JP, CampisiJ, DeGregori J, Laverdiere C, Kokta V, Haddad E, and Beausejour CM. Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell 9: 398-409, 2010.
44. Liang H, Deng L, Chmura S, Burnette B, Liadis N, Darga T, Beckett MA, Lingen MW, Witt M, Weichselbaum RR, and Fu YX. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J Immunol 190: 5874-5881, 2013.
45. Luan Y, Zhang ZH, Wei DE, Zhao JJ, Kong F, Cheng GH, and Wang YB. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension. Am J Med Sci 343: 402-406, 2012.
46. McNulty K and Janes SM. Stem cells and pulmonary fibrosis: cause or cure? Proc Am Thorac Soc 9: 164-171, 2012.
47. Min HJ, Lee Y, Zhao XF, Park YK, Lee MK, Lee JW, and Kim S. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell in-vasion. Cell Signal 26: 398-408, 2014.
48. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11: 59-98, 2009.
49. Munshi HG and Stack MS. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25: 45-56, 2006.
50. Mureli S, Gans CP, Bare DJ, Geenen DL, Kumar NM, and Banach K. Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling. Am J Physiol Heart Circ Physiol 304: H600-H609, 2013.
51. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, and Marshak DR. Multilineage potential of adult human mes-enchymal stem cells. Science 284: 143-147, 1999.
52. Ruegg C, Monnier Y, Kuonen F, and Imaizumi N. Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer 98: 47-57, 2011.
53. Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, and Lesniak MS. Chemokines in tumor progression and metastasis. Onco-target 4: 2171-2185, 2013.
54. Shen Q, Lee ES, Pitts RL, Wu MH, and Yuan SY. Tissue inhibitor of metalloproteinase-2 regulates matrix metallo-proteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvas-cular endothelial cells. Mol Cancer Res 8: 939-951, 2010.
55. Shimizu K, Kinouchi Shimizu N, Asai T, Tsukada H, and Oku N. Enhanced experimental tumor metastasis with age in senescence-accelerated mouse. Biol Pharm Bull 31: 847-851, 2008.
56. Shin JW, Son JY, Raghavendran HR, Chung WK, Kim HG, Park HJ, Jang SS, and Son CG. High-dose ionizing radiation-induced hematotoxicity and metastasis in mice model. Clin Exp Metastasis 28: 803-810, 2011.
57. Slavin S, Kurkalli BG, and Karussis D. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders. Clin Neurol Neurosurg 110: 943-946, 2008.
58. Stewart DJ and Mei SH. Cell-based therapies for lung vascular diseases: lessons for the future. Proc Am Thorac Soc 8: 535-540, 2011.
59. Tchkonia T, Zhu Y, van Deursen J, Campisi J, and Kirk-land JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123: 966-972, 2013.
60. Tsoutsou PG and Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66: 1281-1293, 2006.
61. Tzouvelekis A, Antoniadis A, and Bouros D. Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med 17: 368-373, 2011.
62. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, Zissimopoulos A, Kolios G, Kakagia D, Paspaliaris V, Kotsianidis I, Froudarakis M, and Bouros D. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med 9: 182, 2011.
63. Tzouvelekis A, Ntolios P, and Bouros D. Stem cell treatment for chronic lung diseases. Respiration 85: 179-192, 2013.
64. van Deventer HW, Palmieri DA, Wu QP, McCook EC, and Serody JS. Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. J Immunol 190: 4861-4867, 2013.
65. Wan L, Pantel K, and Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med 19: 1450-1464, 2013.
66. Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, and Zhang B. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 121: 2371-2382, 2011.
67. Wels J, Kaplan RN, Rafii S, and Lyden D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 22: 559-574, 2008.
68. Wen Z, Zheng S, Zhou C, Wang J, and Wang T. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med 15: 1032-1043, 2011.
69. Wirsdorfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Ludemann L, Stuschke M, and Jendrossek V. Thorax irradiation triggers a local and systemic accu-mulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol 9: 98, 2014.
70. Zaleska K, Bruechner K, Baumann M, Zips D, and Yaromina A. Tumour-infiltrating CD11b+myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts. Radiother Oncol 101: 80-85, 2011.
71. Zeng L, Ou G, Itasaka S, Harada H, Xie X, Shibuya K, Kizaka-Kondoh S, Morinibu A, Shinomiya K, and Hiraoka M. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci 99: 2327-2335, 2008.
72. Zhang H, Fang J, Wu Y, Mai Y, Lai W, and Su H. Me-senchymal stem cells protect against neonatal rat hyperoxic lung injury. Expert Opin Biol Ther 13: 817-829, 2013.
73. Zhang Y, Liao S, Yang M, Liang X, Poon MW, Wong CY, Wang J, Zhou Z, Cheong SK, Lee CN, Tse HF, and Lian Q. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplant 21: 2225-2239, 2012.
74. Zhao S, Wehner R, Bornhauser M, Wassmuth R, Bach-mann M, and Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev 19: 607-614, 2010.
75. Zhu Y, Yang Y, Zhang Y, Hao G, Liu T, Wang L, Yang T, Wang Q, Zhang G, Wei J, and Li Y. Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther 5: 48, 2014.